Table 2. Factor Ⅺ (a) inhibitors for thrombosis§ .
Small molecules | Monoclonal antibodies | Aptamers | Antisense oligonucleotides | Natural inhibitors | |
---|---|---|---|---|---|
Mechanism of action | Direct inhibition of FXIa | Direct inhibition of FXI/FXIa | Direct inhibition of FXIa | Inhibition of FXI biosynthesis | Direct inhibition of FXIa |
Route of administration | IV or Oral | IV or SC | IV or SC | SC | IV |
Dosing | Daily | Monthly | Daily | Weekly | Daily |
Onset of action | Minutes/Hours | Hours | Minutes/Hours | Weeks | Minutes |
Offset of action | Minutes/Hours | Weeks | Minutes/Hours | Weeks | Hours |
Medication name | Asundexian | Osocimab | FELIAP | ISIS-FXIRx | Fasxiator |
Milvexian | Abelacimab | 29 nt 11.16 | Fesomersen | Ir-CPI | |
ONO-7684 | Xisomab | 40-nt 12.7 | |||
MK-2060 |
Abbreviations: IV, intravenous; SC, subcutaneous
§Table 2 adapted from [61].